SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John H. Farro who wrote (1628)2/10/1997 7:30:00 PM
From: Richard Mazzarella   of 4342
 
Paracelsian Inc files patent application

ITHACA, N.Y. Feb 10, (Reuter) - Paracelsian Inc said Monday that it has filed a patent application with the U.S.
Patent Trademarks Office relating to ways of inhibiting CD4+T cell depletion induced by HIV-1 infected cells.

The company said its scientists have discovered methods of protecting CD4+T cells which may be useful with
antiviral therapeutics to prevent their loss.

HIV infection eventually produces the loss of CD4+T cells, resulting in the onset of AIDS.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News